| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/30/2010 | US20100247484 Combination therapy of an afucosylated antibody and one or more of the cytokines gm csf, m csf and/or il3 |
| 09/30/2010 | US20100247482 Tight junction modulator peptides for enhanced mucosal delivery of therapeutic compounds |
| 09/30/2010 | US20100247463 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 09/30/2010 | US20100247440 Mycobacterial immunotherapy for cancer treatment |
| 09/30/2010 | US20100247436 In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles |
| 09/30/2010 | US20100247434 Anti-Angiogenic Extracts from Pomegranate |
| 09/30/2010 | US20100247432 Marker for the diagnosis of cancer |
| 09/30/2010 | US20100247431 Polypeptides including modified constant regions |
| 09/30/2010 | US20100247430 Methods and Compositions for Modulating T Cells |
| 09/30/2010 | CA2757224A1 Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof |
| 09/30/2010 | CA2756851A1 Therapeutic agent for cancer having reduced sensitivity to molecular target drug and pharmaceutical composition for enhancing sensitivity to molecular target drug |
| 09/30/2010 | CA2756789A1 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications |
| 09/30/2010 | CA2756533A1 Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates |
| 09/30/2010 | CA2756522A1 Adjuvanting meningococcal factor h binding protein |
| 09/30/2010 | CA2756398A1 Combinations including pneumococcal serotype 14 saccharide |
| 09/30/2010 | CA2756313A1 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 09/30/2010 | CA2756206A1 Methods and compositions for immunization against virus |
| 09/30/2010 | CA2756170A1 Glycoconjugate vaccines |
| 09/30/2010 | CA2756071A1 Rapid antemortem detection of infectious agents |
| 09/30/2010 | CA2755983A1 Compounds and methods for modulating an immune response |
| 09/30/2010 | CA2754531A1 Antibody drug conjugates (adc) that bind to 24p4c12 proteins |
| 09/30/2010 | CA2754393A1 Membrane evaporation for generating highly concentrated protein therapeutics |
| 09/30/2010 | CA2754163A1 Anti-fgfr3 antibodies and methods using same |
| 09/30/2010 | CA2753988A1 Novel anti-.alpha.5.beta.1 antibodies and uses thereof |
| 09/29/2010 | EP2233926A2 Breast Endothelial Cell Expression Patterns |
| 09/29/2010 | EP2233572A2 Genes and polypeptides relating to human colon cancers |
| 09/29/2010 | EP2233571A1 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAS encoding the same |
| 09/29/2010 | EP2233502A1 Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them |
| 09/29/2010 | EP2233501A1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof |
| 09/29/2010 | EP2233153A1 Rotavirus vaccine inducing heterotypic cross protection |
| 09/29/2010 | EP2233152A1 High growth reassortant influenza A virus |
| 09/29/2010 | EP2233151A1 Method of producing japanese encephalitis vaccine stably storable over long time and use of the vaccine |
| 09/29/2010 | EP2233149A1 Combination of BLYS inhibition and anti-CD20 agents for treatment of autoimmune disease |
| 09/29/2010 | EP2232235A2 Analysis of mixtures including proteins |
| 09/29/2010 | EP2231709A1 Bivalent, bispecific antibodies |
| 09/29/2010 | EP2231708A1 Remedies for pemphigus containing anti fas ligand antobodies |
| 09/29/2010 | EP2231707A1 Anti mif antibodies |
| 09/29/2010 | EP2231705A2 Treatment of interstitial cystitis |
| 09/29/2010 | EP2231700A1 Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant |
| 09/29/2010 | EP2231699A2 Vaccines for brucellosis |
| 09/29/2010 | EP2231196A2 Increase of immune response and targeting by antigens and/or drug linkage |
| 09/29/2010 | EP2231187A1 Method of inhibition of leukemic stem cells |
| 09/29/2010 | EP2231186A2 Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins |
| 09/29/2010 | EP2231185A1 Methods and compositions for treating liquid tumors |
| 09/29/2010 | EP2231184A1 Cd24 as a brain tumor stem cell marker and a diagnostic and therapeutic target in primary neaural and glial tumors of the brain |
| 09/29/2010 | EP2231183A2 Therapy of rituximab-refractory rheumatoid arthritis patients |
| 09/29/2010 | EP2231181A1 New vaccine for the treatment of mycobacterium related disorders |
| 09/29/2010 | EP2231180A2 Vaccine for alzheimer's disease |
| 09/29/2010 | EP2231175A2 Protein formulations and methods of making same |
| 09/29/2010 | EP2231172A1 Immunomodulating compositions and uses therefor |
| 09/29/2010 | EP2231145A2 Use of glycosylceramides for enhancing the immune response to antigens |
| 09/29/2010 | EP2083856B1 Peptides for desensibilization against allergens |
| 09/29/2010 | EP1929034B1 Cancerous disease modifying antibodies |
| 09/29/2010 | EP1729803B1 Therapeutic use of anti-cs1 antibodies |
| 09/29/2010 | EP1534695B1 Tyrosine kinase inhibitors |
| 09/29/2010 | EP1476120B1 Treatment methods using anti-cd22 antibodies |
| 09/29/2010 | EP1223956B1 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 09/29/2010 | EP1095274B1 Trifunctional reagent for conjugation to a biomolecule |
| 09/29/2010 | EP1028972B1 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes |
| 09/29/2010 | CN101849013A Raccoon poxvirus expressing genes of feline antigens |
| 09/29/2010 | CN101849006A Improved antibody molecule |
| 09/29/2010 | CN101849001A Methods of modifying antibodies, and modified antibodies with improved functional properties |
| 09/29/2010 | CN101848999A Anti-CD20 monoclonal antibodies |
| 09/29/2010 | CN101848998A Anti-EPHA2 antibody |
| 09/29/2010 | CN101848937A Molecules and methods for modulating complement component |
| 09/29/2010 | CN101848929A Streptococcus pneumoniae pilus antigens |
| 09/29/2010 | CN101848733A Methods and compositions for pulmonary administration of a TNFalpha inhibitor |
| 09/29/2010 | CN101848732A Methods of reducing eosinophil levels |
| 09/29/2010 | CN101848731A Methods for the directed expansion of epitopes for use as antibody ligands |
| 09/29/2010 | CN101848730A Capsid proteins and uses therefore |
| 09/29/2010 | CN101848729A Adenoviral vector encoding malaria antigen |
| 09/29/2010 | CN101848724A Use of TRL-2 antagonists for treatment of reperfusion injury and tissue damage |
| 09/29/2010 | CN101848707A Carrier particle for a microorganism or subunit thereof, pharmaceutical composition comprising such particles, method for preparation of this composition and its use in the treatment of animals |
| 09/29/2010 | CN101845456A Corn expression vector of tubercle Ag85B gene and application thereof |
| 09/29/2010 | CN101845455A Corn expression vector of Hepatitis B virus L gene and application thereof |
| 09/29/2010 | CN101845449A Fusion gene of Hepatitis B virus L gene and tubercle Esat6 and construction and application of expression vector thereof |
| 09/29/2010 | CN101845438A Sensitive diagnosis and relative treatment for cancers through 20 tumor specific related genes and products |
| 09/29/2010 | CN101845419A Recombinant adenovirus and application thereof |
| 09/29/2010 | CN101845084A Recombination polypeptide serving as group A streptococcic tetravalent vaccine protective antigen |
| 09/29/2010 | CN101845083A Synthetic peptide vaccine for treating porcine reproductive and respiratory syndrome and preparation method thereof |
| 09/29/2010 | CN101843903A Method for inhibiting activation of platelet and application thereof |
| 09/29/2010 | CN101843902A Method for preparing polyvalent antiserum for resisting venin of common terrestrial viperidae venomous snakes in China and application thereof |
| 09/29/2010 | CN101843901A Influenza virus vaccine using nanometer emulsion as adjuvant and method for preparing same |
| 09/29/2010 | CN101843900A Bird flu inactivated vaccine and preparation method thereof |
| 09/29/2010 | CN101843899A Methicillin-resistant staphylococcus aureus (MRSA) recombinant multivalent subunit genetic engineering vaccine and method for preparing same |
| 09/29/2010 | CN101843897A Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101508977B Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof |
| 09/29/2010 | CN101220096B Preparation and application of humanized anti-spasmotoxin monoclone antibody |
| 09/29/2010 | CN101175495B Anti-cancer compound combination |
| 09/29/2010 | CN101099864B Method for preparing inactivated vaccine both for preventing chicken Newcastle disease and infectious bronchitis |
| 09/29/2010 | CN101099863B Method for preparing triple inactivated vaccine for preventing chicken Newcastle disease, infectious bronchitis and egg drop syndrome |
| 09/28/2010 | US7803926 Immunology; immunogens; cloning; host cell biosynthesis |
| 09/28/2010 | US7803924 Polynucleotide encoding a protein that is highly immunogenic especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens |
| 09/28/2010 | US7803918 gene delivery vehicle comprising the isolated and/or recombinant nucleic acid sequence; methods for typing the virus in various samples and diagnosing of disease |
| 09/28/2010 | US7803916 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine; 22P4F11 transcript and/or protein represent a useful diagnostic marker and/or therapeutic target for prostate cancer |
| 09/28/2010 | US7803915 Ati-TAT88 polypeptide antibody; Anticarcinogenic agent; expression vector containign a nucleic acid operably linked to control sequences recognized by a host cell transformed with the vector |
| 09/28/2010 | US7803913 Identifying preferential immunoglobulins for use in treatment and prevention of infections and cell proliferative disorders via repeated screening of phage library |
| 09/28/2010 | US7803909 Truncated tyrosine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/28/2010 | US7803904 Mucosal vascular addressing and uses thereof |